Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)
HS4 ID 3003
1.87M €
Exports
2023
2004 January2024 August
17.8M €
Imports
2023
2004 January2024 August
pl
Peamine Sihtriik
ch
Peamine Saatjariik
Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) is the 591st most traded HS4 level product.
In 2023, the top countries where Estonia exported Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) to were Poland (€714k), Austria (€467k), Latvia (€370k), Lithuania (€272k), and Spain (€21.8k). During the same period, Estonia imported Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) from Switzerland (€11.5M), Malta (€3.26M), Germany (€1.12M), Poland (€407k), and Lithuania (€388k).
Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) is a 4 digit product (HS4 ID 3003).
Export
2023
This chart shows the shares of countries where Estonia exports Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) to.
Import
2023
This chart shows the shares of countries where Estonia imports Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) from.
Trade Balance
As of 2024 August, Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) had negative trade balance of €996k. In 2023 August, it had negative trade balance of €626k.
